Medtech and Biotech companies that prioritize professional development and career growth can reduce turnover and attract new talent. Here is how one company is standing out in a highly competitive employment market.
Medtech and Biotech companies that prioritize professional development and career growth can reduce turnover and attract new talent. Here is how one company is standing out in a highly competitive employment market.
Many younger employees need the interaction of in-person work. But to encourage a broader return to in-person work, organizations must make a compelling case for the benefits it brings employees. At the same time, they need to toss out the old office paradigm and transform to one that celebrates the new world of work.
Not talking, doing is the mantra of the medtech professionals behind Diversity by Doing (DxD), an organization committed to helping small- to mid-sized medtech companies build a foundation of diversity, equity and inclusion into their companies’ DNA.
JABIL Cayey is the first manufacturer in Puerto Rico to receive plastics injection molding accreditation through the industry-managed supply chain oversight program.
The pandemic and resulting “Great Resignation” is forcing companies to re-examine their workplace cultures and employee needs. Luke Otto, executive recruiting manager at Actalent, shares insights into what today’s medtech teams are seeking in an employer.
The upcoming revision to ISO 10993-17 proposes the use of release kinetics data to support toxicological risk assessments. Manufacturers should expect that this data will be needed to help mitigate the risks identified in exhaustive extraction studies.
Nondisclosure agreements (NDAs) can help protect trade secrets and build a framework for better cooperation and understanding between parties. Following are some key areas to consider when creating an NDA.
MedExecWomen board President, Helen Routh, noted at a recent conference: “Innovation in healthcare, particularly post-COVID, requires us to work across industry sectors, alongside clinicians and payers.” Laurie Halloran, president & CEO of Halloran Consultant Group shares insights she heard from a panel of strong female leaders on how the industry can take action to improve health inequities, which will be an ongoing topic at future conferences.
How can AI become a beneficial medical device manufacturing technology? This article reviews some examples of how it excels.
New changes mean new challenges, but global harmonization could make things easier for device manufacturers in the long run.